These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 17009926)

  • 41. Nicotinic acetylcholine receptors at the single-channel level.
    Bouzat C; Sine SM
    Br J Pharmacol; 2018 Jun; 175(11):1789-1804. PubMed ID: 28261794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer's Dementia: An Update.
    Hoskin JL; Al-Hasan Y; Sabbagh MN
    Nicotine Tob Res; 2019 Feb; 21(3):370-376. PubMed ID: 30137524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
    Ma KG; Qian YH
    Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The current agonists and positive allosteric modulators of
    Yang T; Xiao T; Sun Q; Wang K
    Acta Pharm Sin B; 2017 Nov; 7(6):611-622. PubMed ID: 29159020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.
    Zoli M; Pucci S; Vilella A; Gotti C
    Curr Neuropharmacol; 2018; 16(4):338-349. PubMed ID: 28901280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alzheimer's disease: Targeting the Cholinergic System.
    Ferreira-Vieira TH; Guimaraes IM; Silva FR; Ribeiro FM
    Curr Neuropharmacol; 2016; 14(1):101-15. PubMed ID: 26813123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alzheimer's Disease Therapeutic Approaches.
    Revi M
    Adv Exp Med Biol; 2020; 1195():105-116. PubMed ID: 32468465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Basal forebrain subcortical projections.
    Agostinelli LJ; Geerling JC; Scammell TE
    Brain Struct Funct; 2019 Apr; 224(3):1097-1117. PubMed ID: 30612231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia.
    Knight R; Khondoker M; Magill N; Stewart R; Landau S
    Dement Geriatr Cogn Disord; 2018; 45(3-4):131-151. PubMed ID: 29734182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs.
    Bagdas D; Gurun MS; Flood P; Papke RL; Damaj MI
    Curr Neuropharmacol; 2018; 16(4):415-425. PubMed ID: 28820052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.
    Ballinger EC; Ananth M; Talmage DA; Role LW
    Neuron; 2016 Sep; 91(6):1199-1218. PubMed ID: 27657448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders.
    Kalkman HO; Feuerbach D
    Cell Mol Life Sci; 2016 Jul; 73(13):2511-30. PubMed ID: 26979166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J; Wu J
    Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of the Macrophage α7 Nicotinic Acetylcholine Receptor and Control of Inflammation.
    Báez-Pagán CA; Delgado-Vélez M; Lasalde-Dominicci JA
    J Neuroimmune Pharmacol; 2015 Sep; 10(3):468-76. PubMed ID: 25870122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acetylcholine and attention.
    Klinkenberg I; Sambeth A; Blokland A
    Behav Brain Res; 2011 Aug; 221(2):430-42. PubMed ID: 21108972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system.
    Taly A; Corringer PJ; Guedin D; Lestage P; Changeux JP
    Nat Rev Drug Discov; 2009 Sep; 8(9):733-50. PubMed ID: 19721446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy.
    Steinlein OK; Mulley JC; Propping P; Wallace RH; Phillips HA; Sutherland GR; Scheffer IE; Berkovic SF
    Nat Genet; 1995 Oct; 11(2):201-3. PubMed ID: 7550350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders.
    Bertrand D; Wallace TL
    Curr Top Behav Neurosci; 2020; 45():1-28. PubMed ID: 32451956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced
    Talvio K; Minkeviciene R; Townsley KG; Achuta VS; Huckins LM; Corcoran P; Brennand KJ; Castrén ML
    Front Cell Dev Biol; 2022; 10():1034679. PubMed ID: 36506088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.